Analyze This: Looking at the State of Medtech Startups

MedTech Innovator’s Paul Grand and Deloitte’s Glenn Snyder unveil the results of a study aimed at device startups in this episode of Let’s Talk Medtech.

Omar Ford

December 17, 2021

1 Min Read
GP3ND2.jpg
Anna Berkut / Alamy Stock Photo

Deloitte and MedTech Innovator (MTI) have conducted an analysis of never before seen insights found in medtech startups.

The report looked at a database of approximately 1,000 applicants from MTI’s 2021 Accelerator program and interviewed leaders from startups and medtech companies that could be strategic acquirers. 

MedTech Innovator’s CEO, Paul Grand and Glenn Synder, Deloitte's Principle MedTech Practice Leader discuss the study’s finding on this episode of Let’s Talk Medtech.

 

 

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like